![(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide [1934246-20-4] (S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide [1934246-20-4]](https://www.targetmol.com/group3/M00/02/C4/CgoaEWY7N7WELY1FAAAAAJaosdM084.png)
(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide [1934246-20-4]
T60186
Overview
- SupplierTargetMol Chemicals
- Product Name(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide [1934246-20-4]
- Delivery Days Customer9
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical Name(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide
- Estimated Purity99.87%
- Molecular FormulaC26H23F3N6O
- Molecular Weight492.5
- Scientific DescriptionMitoBloCK-6 is an effective inhibitor of Erv1/ALR with IC50 values of 900 nM and 700 nM, respectively. Additionally, MitoBloCK-6 inhibits Erv2 (IC50=1.4 microM). It induces apoptosis in hESCs by promoting the release of cytochrome c.
- Shelf life instruction3 years
- SMILESC[C@H]1C=2C(CN(C1)C=3C=NC=NC3)=CC(C(NC4=CC(=CC(C(F)(F)F)=C4)N5C=NC(C)=C5)=O)=CC2
- Storage Instruction-20°C
- UNSPSC12352200